Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines.
| Autor: | Grundy, Quinn, Huyer, Larkin Davenport, Parker, Lisa, Bero, Lisa |
|---|---|
| Předmět: |
HEALTH policy
OCCUPATIONAL roles NURSING SOCIAL support ATTITUDES of medical personnel CHRONIC diseases PATIENT-centered care MARKETING NURSE-patient relationships PATIENTS' attitudes QUALITATIVE research CONTINUUM of care DRUG administration DRUGS RESEARCH funding NURSES DRUG monitoring COMMUNICATION ENDOWMENTS PHARMACEUTICAL industry HOLISTIC nursing NURSING ethics PATIENT education SECONDARY analysis PATIENT safety |
| Zdroj: | Policy, Politics & Nursing Practice; Feb2023, Vol. 24 Issue 1, p67-75, 9p |
| Abstrakt: | An increasing proportion of new drugs approved for market worldwide are now high cost, specialty medicines. Pharmaceutical marketers face the challenge of convincing payers, prescribers, and patients that the cost and complexity of care associated with specialty medicines is worth the trouble, and now offer patient support programs, free of charge, to patients prescribed their drug. We conducted a secondary, qualitative, interpretive analysis of 24 interviews with leaders of patient groups and members of hospital formulary committees in Australia to describe the work of pharmaceutical company-employed or contracted nurses who provide support to patients prescribed specialty medicines, and to prompt discussion around the policy implications of relying on industry-funded nursing care within publicly funded health systems. Participants affirmed the value of specialist, holistic, person-centered nursing care, but perceived gaps within the public health system related to the availability and provision of nursing care for people living with chronic disease. Consequently, participants described the pharmaceutical industry as addressing health system gaps through sponsorship or direct provision of medication-related nursing care, but recognized that care was contingent on commercial interest. Participants highlighted a number of ethical and policy concerns stemming from industry-funded nursing care of people prescribed specialty medicines related to patient safety, continuity of care, inducement to prescribe, and health equity. This analysis suggests that outsourcing necessary medication-related care to pharmaceutical companies has implications for the health system and equitable, sustainable pharmaceutical policy that extend far beyond the care encounter. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|